Protagonist Therapeutics Inc (PTGX)
39.30
-1.30
(-3.20%)
USD |
NASDAQ |
Dec 24, 16:00
Protagonist Therapeutics Cash from Investing (Quarterly): -208.71M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Assembly Biosciences Inc | 24.49M |
| Precision BioSciences Inc | -0.064M |
| Entrada Therapeutics Inc | -82.93M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.86M |
| Cash from Financing (Quarterly) | 12.05M |
| Free Cash Flow | 229.23M |
| Free Cash Flow Per Share (Quarterly) | -0.4636 |
| Free Cash Flow to Equity (Quarterly) | -28.64M |
| Free Cash Flow to Firm (Quarterly) | -28.64M |
| Free Cash Flow Yield | 9.44% |